3623 results for «2483»

Filter By

3623 results

Coronary scaffolds: new developments and applications

21 May 2025 – From EuroPCR 2025

Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.

Coronary scaffolds: new developments and applications

Challenging scenarios in patient with multivessel disease

20 May 2025 – From EuroPCR 2025

Explore challenging clinical scenarios in patients with multivessel coronary artery disease. This session presents complex cases such as coronary aneurysms, failed bypass grafts, limitations of intravascular lithotripsy, and rare pathologies like Takayasu’s arteritis, highlighting decision-making and advanced intervention strategies.

Challenging scenarios in patient with multivessel disease

Mitral TEER in challenging scenarios - Part 2

21 May 2025 – From EuroPCR 2025

This session focuses on challenging scenarios encountered during mitral transcatheter edge-to-edge repair (TEER). Learn about management of complications such as haemolysis, device malfunctions, and complex vascular access issues, supported by instructive case presentations including bailout strategies in cardiogenic shock and infective endocarditis.

Mitral TEER in challenging scenarios - Part 2

Beyond the intervention: outcomes of CTO PCI

22 May 2025 – From EuroPCR 2025

Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.

Beyond the intervention: outcomes of CTO PCI

TAVI - Outcomes predictors

22 May 2025 – From EuroPCR 2025

Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.

TAVI - Outcomes predictors

Retrograde removal of the broken sheath

22 May 2025 – From EuroPCR 2025

This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.

Retrograde removal of the broken sheath

TAVI for aortic regurgitation off label

22 May 2025 – From EuroPCR 2025

Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.

TAVI for aortic regurgitation off label

Acute complications during distal left main PCI - Part 3

22 May 2025 – From EuroPCR 2025

This session highlights acute complications during distal left main PCI. It presents cautionary cases of incorrect left main stenting, catastrophic left main V stenting outcomes, unprotected left main thrombosis, and survival strategies when new technologies fail unexpectedly.

Acute complications during distal left main PCI - Part 3

Peripheral interventions: the hidden key for complications

22 May 2025 – From EuroPCR 2025

Uncover the critical role of peripheral interventions in managing complications. This session shares case stories of lost stents, unusual TAVI access complications, percutaneous removal of misplaced devices, revascularisation of iatrogenic pseudoaneurysms, and challenges when multiple closure devices are insufficient.

Peripheral interventions: the hidden key for complications

Electrosurgical techniques in transcatheter mitral valve replacement

22 May 2025 – From EuroPCR 2025

Delve into electrosurgical techniques in transcatheter mitral valve replacement. This session covers advanced methods including the tip-to-base lampoon technique, electrosurgical laceration of failed devices, left ventricular outflow tract obstruction management, combined septal ablation and valve-in-valve procedures, and management of severe aortic regurgitation post-laceration.

Electrosurgical techniques in transcatheter mitral valve replacement

Calcified un-dilatable lesions in ACS: what should I do?

22 May 2025 – From EuroPCR 2025

Address the challenges of severely calcified undilatable lesions during acute coronary syndrome PCI. This session reviews the impact of coronary calcification on PCI strategy, highlights pitfalls in lesion preparation, and presents detailed case studies demonstrating effective treatment approaches.

Calcified un-dilatable lesions in ACS: what should I do?

Which device for which patient: DES, BRS or DCB?

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.

Which device for which patient: DES, BRS or DCB?

Innovative strategies for coronary interventions

22 May 2025 – From EuroPCR 2025

Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...

Innovative strategies for coronary interventions

Emerging indications for TAVI in 2025

22 May 2025 – From EuroPCR 2025

Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.

Emerging indications for TAVI in 2025

TAVI in women

22 May 2025 – From EuroPCR 2025

Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...

TAVI in women

Innovations in transcatheter aortic valve devices and techniques

22 May 2025 – From EuroPCR 2025

Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...

Innovations in transcatheter aortic valve devices and techniques

Integrating CT coronary angiography into your PCI practice

22 May 2025 – From EuroPCR 2025

Integrate CT coronary angiography into your PCI practice to enhance procedural planning and outcomes. This session covers practical CT-based approaches for guiding catheter selection, lesion analysis, and stenting strategy. Learn how to leverage CT imaging to anticipate plaque preparation needs in calcified lesions and optimize catheterization...

Integrating CT coronary angiography into your PCI practice

Procedural aspects of DCB PCI

22 May 2025 – From EuroPCR 2025

Delve into procedural aspects of drug-coated balloon (DCB) PCI with a focus on lesion preparation, antiplatelet therapy, and outcomes in real-world settings. This session reviews the impact of pre-dilatation balloons on de novo lesions, compares ticagrelor versus clopidogrel post-PCI with drug-eluting balloons, and discusses streamlined revascularization...

Procedural aspects of DCB PCI

The calcium challenge: stent avoidance and in-stent restenosis treatment

22 May 2025 – From EuroPCR 2025

Confront the challenges posed by coronary calcium through innovative stent avoidance and in-stent restenosis treatment strategies. This session features analyses on the feasibility of intravascular lithotripsy (IVL) alone, its use prior to drug-coated balloon angioplasty, and in treating in-stent restenosis. Outcomes following IVL-assisted PCI are reviewed...

The calcium challenge: stent avoidance and in-stent restenosis treatment

From evidence to practice: solving complex cases with EuroIntervention

22 May 2025 – From EuroPCR 2025

Translate evidence into clinical practice with this session focusing on complex case analyses supported by EuroIntervention resources. Experience detailed presentations of challenging PCI, intracoronary imaging, coronary physiology, and TAVI cases, each followed by evidence-based solutions provided through EuroIntervention. Enhance your decision-making skills by integrating guidelines and...

From evidence to practice: solving complex cases with EuroIntervention
Didn’t find what you were looking for?